Folks, Vericel announced today that it received FDA Fast Track designation for its ixmyelocel‑T product for treatment of advanced heart failure due to dilated cardiomyopathy.
So why am I posting this news about Vericel on this board?
Let's compare Mesoblast to Vericel.
Back in April 2016, Vericel's ixmyelocel‑T product failed to meet it's secondary endpoints of heart-pumping efficiency and six-minute walking distance in the Phase 2b trial.
You read that right - it FAILED to meet it's secondary endpoints. And that was in the Phase 2b trial.
Plus, ixmyelocel‑T is autologous, which means it takes a patient's own stem cells.
As opposed to allogeneic, which is Mesoblast's products. Lookup the comparison advantages of allogeneic vs. autologous especially with respect to mass commercialization and ready, off-the-shelf availability.
Mesoblast's CHF therapy is light years ahead of Vericel's in its efficacy and commercial viability.
And Mesoblast is way past Phase 2 in CHF.
So. The. FDA. Just. Granted. Vericel. Fast. Track. Designation for its ixmyelocel‑T product.
Over and out.
Tick, tock, tick, tock..............
- Forums
- ASX - By Stock
- MSB
- Heart Failure
Heart Failure
-
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.10 |
Change
-0.023(2.00%) |
Mkt cap ! $1.261B |
Open | High | Low | Value | Volume |
$1.14 | $1.16 | $1.09 | $3.878M | 3.483M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 91504 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.11 | 60062 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 112907 | 1.100 |
20 | 455883 | 1.095 |
24 | 185837 | 1.090 |
13 | 109344 | 1.085 |
19 | 808543 | 1.080 |
Price($) | Vol. | No. |
---|---|---|
1.105 | 51080 | 12 |
1.110 | 132549 | 12 |
1.115 | 103027 | 9 |
1.120 | 116700 | 5 |
1.125 | 117500 | 3 |
Last trade - 12.04pm 29/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |